John T. Kemshead

1.5k total citations
35 papers, 1.2k citations indexed

About

John T. Kemshead is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, John T. Kemshead has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 15 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Molecular Biology. Recurrent topics in John T. Kemshead's work include Neuroblastoma Research and Treatments (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). John T. Kemshead is often cited by papers focused on Neuroblastoma Research and Treatments (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). John T. Kemshead collaborates with scholars based in United Kingdom, United States and Japan. John T. Kemshead's co-authors include Jeremy A. Garson, H.B. Coakham, Tohru Sugimoto, Alan R. Hipkiss, M. J. Embleton, Peter L. Stern, Eleanor J. Cheadle, Joely J. Irlam, Kerry Chester and David Shaw and has published in prestigious journals such as Nucleic Acids Research, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

John T. Kemshead

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John T. Kemshead United Kingdom 18 464 437 258 233 225 35 1.2k
Shahar Frenkel Israel 22 556 1.2× 399 0.9× 216 0.8× 354 1.5× 183 0.8× 78 1.6k
Valentina Ciccarone United States 14 746 1.6× 641 1.5× 266 1.0× 517 2.2× 420 1.9× 28 1.5k
Chien‐Tsun Kuan United States 23 734 1.6× 655 1.5× 115 0.4× 468 2.0× 442 2.0× 37 1.6k
O. A. Jensen Denmark 23 645 1.4× 514 1.2× 131 0.5× 286 1.2× 166 0.7× 109 2.0k
Vikas Khetan India 21 825 1.8× 603 1.4× 82 0.3× 233 1.0× 179 0.8× 119 1.8k
Gloria Balaban United States 19 1.0k 2.2× 630 1.4× 398 1.5× 114 0.5× 209 0.9× 23 1.7k
Syed R. Husain United States 30 688 1.5× 772 1.8× 210 0.8× 384 1.6× 1.2k 5.3× 54 2.5k
Maxim Koslow United States 14 426 0.9× 497 1.1× 209 0.8× 76 0.3× 126 0.6× 27 1.3k
Kevin C. Graham Canada 15 857 1.8× 284 0.6× 91 0.4× 147 0.6× 75 0.3× 25 1.3k
Hong-Fen Guo United States 25 783 1.7× 1.1k 2.5× 555 2.2× 551 2.4× 608 2.7× 50 2.0k

Countries citing papers authored by John T. Kemshead

Since Specialization
Citations

This map shows the geographic impact of John T. Kemshead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Kemshead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Kemshead more than expected).

Fields of papers citing papers by John T. Kemshead

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Kemshead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Kemshead. The network helps show where John T. Kemshead may publish in the future.

Co-authorship network of co-authors of John T. Kemshead

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Kemshead. A scholar is included among the top collaborators of John T. Kemshead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Kemshead. John T. Kemshead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pizer, Barry, et al.. (2008). A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in children. British Journal of Haematology. 77(4). 466–472. 2 indexed citations
3.
Guest, Ryan D., Robert E. Hawkins, Н. А. Кириллова, et al.. (2005). The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors. Journal of Immunotherapy. 28(3). 203–211. 255 indexed citations
4.
Coakham, H.B. & John T. Kemshead. (1998). Treatment of neoplastic meningitis by targeted radiation using 131I-radiolabelled monoclonal antibodies. Journal of Neuro-Oncology. 38(2-3). 225–232. 41 indexed citations
5.
Zhu, Ning, John Kenealy, Andrew Burd, et al.. (1997). Sub-lethal effects of exposing the human melanoma cell line Skmel−23 to 532 nm laser light. International Journal of Cancer. 72(6). 1104–1112. 18 indexed citations
6.
Aigner, Silke, et al.. (1996). L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin. European Journal of Immunology. 26(10). 2508–2516. 98 indexed citations
7.
Pizer, Barry, et al.. (1995). Pharmacokinetics and dose estimates following intrathecal administration of 131I-monoclonal antibodies for the treatment of central nervous system malignancies. International Journal of Radiation Oncology*Biology*Physics. 31(3). 541–552. 21 indexed citations
8.
Kemshead, John T., et al.. (1994). Immunomagnetic Colloids for the Enrichment of Tumor Cells from Peripheral Blood and Bone Marrow: A Model System. Journal of Hematotherapy. 3(1). 51–57. 2 indexed citations
9.
Pizer, Barry & John T. Kemshead. (1994). The Potential of Targeted Radiotherapy in the Treatment of Central Nervous System Leukaemia. Leukemia & lymphoma. 15(3-4). 281–289. 8 indexed citations
10.
Kemshead, John T.. (1992). Immunomagnetic Manipulation of Hematopoietic Cells: A Review of Current Technology. Journal of Hematotherapy. 1(1). 35–44. 8 indexed citations
11.
Malik, Afshan N., et al.. (1992). A discordance between the human muscle NCAM sequence and those seen in other NCAM cDNA clones. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1130(1). 95–96. 1 indexed citations
12.
Kemshead, John T., et al.. (1992). Monoclonal antibodies in the treatment of central nervous system malignancies. European Journal of Cancer. 28(2-3). 511–513. 23 indexed citations
13.
Patel, Kalpana, et al.. (1992). X-linked gene MIC5 codes for the L1 adhesion molecule recognized by monoclonal antibody R1. Cancer Genetics and Cytogenetics. 60(1). 20–22. 1 indexed citations
14.
Sugimoto, Tohru, Hisao Ueyama, Hajime Hosoi, et al.. (1991). Alpha‐smooth‐muscle actin and desmin expressions in human neuroblastoma cell lines. International Journal of Cancer. 48(2). 277–283. 34 indexed citations
15.
Kemshead, John T.. (1991). Immunodiagnosis of cancer. Immunology Today. 12(11). 424–425. 7 indexed citations
16.
Horii, Yoshihiro, Hajime Hosoi, Johji Inazawa, et al.. (1990). Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over‐expression of the N‐myc oncogene. International Journal of Cancer. 45(4). 705–711. 20 indexed citations
17.
He, Xuanmin, Stephen X. Skapek, Carol J. Wikstrand, et al.. (1989). Phenotypic Analysis of Four Human Medulloblastoma Cell Lines and Transplantable Xenografts. Journal of Neuropathology & Experimental Neurology. 48(1). 48–68. 74 indexed citations
18.
Lashford, L. S., Alun Davies, Richard B. Richardson, et al.. (1988). A pilot study of131I monoclonal antibodies in the therapy of leptomeningeal tumors. Cancer. 61(5). 857–868. 87 indexed citations
19.
Sugimoto, Tohru, Tadashi Sawada, Takafumi Matsumura, et al.. (1988). Diagnosis of neuroblastoma metastasis in bone marrow with a panel of monoclonal antibodies. Medical and Pediatric Oncology. 16(3). 190–196. 13 indexed citations
20.
Vivian, G., et al.. (1984). Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13A. The Journal of Pediatrics. 105(2). 252–256. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shahar Frenkel Breakdown of academic impact, for papers by Valentina Ciccarone Breakdown of academic impact, for papers by Chien‐Tsun Kuan Breakdown of academic impact, for papers by O. A. Jensen Breakdown of academic impact, for papers by Vikas Khetan Breakdown of academic impact, for papers by Gloria Balaban Breakdown of academic impact, for papers by Syed R. Husain Breakdown of academic impact, for papers by Maxim Koslow Breakdown of academic impact, for papers by Kevin C. Graham Breakdown of academic impact, for papers by Hong-Fen Guo
Rankless by CCL
2026